Symbol="RETA"
AssetType="Common Stock"
Name="Reata Pharmaceuticals Inc"
Description="Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops novel therapies for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cell metabolism and inflammation. The company is headquartered in Plano, Texas."
CIK="1358762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="5320 LEGACY DRIVE, PLANO, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3919240000"
EBITDA="-323340000"
PERatio="None"
PEGRatio="0"
BookValue="-3.482"
DividendPerShare="0"
DividendYield="0"
EPS="-11.26"
RevenuePerShareTTM="0.041"
ProfitMargin="0"
OperatingMarginTTM="-216.73"
ReturnOnAssetsTTM="-0.358"
ReturnOnEquityTTM="-5.19"
RevenueTTM="1497000"
GrossProfitTTM="-167627000"
DilutedEPSTTM="-11.26"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.787"
AnalystTargetPrice="115.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="414.73"
PriceToBookRatio="285.94"
EVToRevenue="316.34"
EVToEBITDA="-3.746"
Beta="1.369"
num_52WeekHigh="108.5"
num_52WeekLow="18.47"
num_50DayMovingAverage="94.73"
num_200DayMovingAverage="61.56"
SharesOutstanding="33036100"
DividendDate="None"
ExDividendDate="None"
symbol="RETA"
open="108.00"
high="108.50"
low="103.78"
price="104.37"
volume="634840.00"
latest_trading_day="2023-07-07"
previous_close="107.89"
change="-3.52"
change_percent="-3.2626%"
aroon_positive_momentum_days="71"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="71"
Volume_recent_avg="1247455"
Change_recent_avg="0.13"
Delta_recent_avg="4.93"
Variance_recent_avg="2.46"
Change_ratio_recent_avg="-0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="71"
Aroon_momentum_negative="29"
image_negative_thumbnail_id_1="1160"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0194.jpeg"
image_negative_thumbnail_id_2="1095"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0128.jpeg"
image_neutral_thumbnail_id_1="591"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_neutral_thumbnail_id_2="578"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_positive_thumbnail_id_1="691"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0017.jpeg"
image_positive_thumbnail_id_2="998"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
